Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.

Using an ophthalmic exoscope with an augmented reality headset instead of a standard operating microscope may yield ergonomic ...

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to ...

CeraVe and Neutrogena over-the-counter products topped the U.S. News & World Report third annual Best OTC Medicine & Health ...

When we are looking at the role of a mental health professional, we are bridging this gap between physical healing and ...

A carotid stenting system was linked to the lowest 1-year stroke rates reported for any prospective, multicenter pivotal ...

Treatment with stimulants is unlikely to cause psychotic symptoms in children with ADHD, according to a new study published ...

Annual universal depression screening for adolescents during primary care visits is cost effective, especially for certain ...

A new all-in-one pulsed field ablation catheter system demonstrated durable pulmonary vein isolation and a promising safety ...

More daily steps and less sedentary behavior were associated with reduced risk for all-cause and cardiovascular disease ...